Insight Molecular Diagnostics Inc. (IMDX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$2.90

From 52W high−65.92%

Volume473003.00

Market cap$94.57M

P/E (TTM)—

P/S (TTM)56.6x

Div yield—

Key dataOct 19, 2026

Open

$2.90

From 52W high

−65.92%

Volume

473003.00

Market cap

$94.57M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.7x

P/E (TTM)

—

RSI (14)

36.5

MomentumView details →

1D Return

−3.99%

YTD Return

−61.60%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.7x

EV/Sales

47.6x

P/S (TTM)

56.6x

P/B (TTM)

−4.4x

ProfitabilityView details →

Gross Margin

11.17%

Net Margin

−2955.63%

EBITDA Margin

−2803.47%

ROE (TTM)

231.74%

ROA (TTM)

−167.64%

Asset Turnover

0.05x

GrowthView details →

Revenue YoY

−60.77%

EPS YoY

+56.27%

FCF YoY

−30.29%

Revenue CAGR 3Y

+61.76%

EPS CAGR 3Y

+64.60%

EBITDA YoY

+23.69%

MomentumView details →

1D Return

−3.99%

YTD Return

−61.60%

1Y Return

−51.10%

RSI (14)

36.5

vs 50D SMA

−25.38%

vs 200D SMA

−41.55%

Capital & dividendView details →

Debt/Equity

−0.12x

Current Ratio

2.00x

Quick Ratio

1.98x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.31

EPS Surprise

−22.07%

Beats (12Q)

7/12

Next Q EPS Est

−$0.23

Avg Surprise (4Q)

42.20%

Rev Surprise

−45.37%

Financials snapshotView financials →

Revenue (TTM)

1.67M

Net Income (TTM)

−49.36M

Op. CF (TTM)

−26.95M

Next earningsNov 9, 2026 →

Latest newsMore news →

Insight Molecular Diagnostics Inc. appointed Donnie Purto as Senior Vice President of Sales.6d ago

Insight Molecular Diagnostics Inc. amended its merger agreement with Chronix to replace earnout consideration with a 10% royalty on CNI Monitor sales, payable until a CNI Monitor sale or IP expiration.28d ago

Similar companies

PMV Pharmaceuticals, Inc.PMVP Immunic, Inc.IMUX Polaryx Therapeutics, Inc. Common StockPLYX ImmuCell CorporationICCC Conexeu Sciences Inc.CNXU Cellectis S.A.CLLS Find similar companies →

Latest newsMore news →

Insight Molecular Diagnostics Inc. appointed Donnie Purto as Senior Vice President of Sales.6d ago Insight Molecular Diagnostics Inc. amended its merger agreement with Chronix to replace earnout consideration with a 10% royalty on CNI Monitor sales, payable until a CNI Monitor sale or IP expiration.28d ago